ONWARD Medical N.V. announced the company and its partners have been awarded nine new patents, seven of them in collaboration with leading neuroscience research laboratories at Caltech, UCLA, EPFL, and University of Louisville. The patents cover a broad range of technologies and activities encompassing ONWARD's implantable and external technology platforms, ARCIM and ARCEX, and protecting key elements of those systems such as lead designs, spinal cord stimulation paradigms, closed-loop control systems and machine learning algorithms. The patents were awarded in the US, France, Canada, and Germany.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
4.63 EUR | -0.22% | -8.86% | +49.35% |
Apr. 25 | Onward Medical N.V. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 02 | Onward Medical Seeks US FDA Nod to Market Spinal Cord Stimulation Therapy | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+49.35% | 172M | |
+72.61% | 12.34B | |
-17.97% | 7.96B | |
+16.59% | 7.16B | |
+5.08% | 5.72B | |
+6.51% | 5.03B | |
+21.99% | 4.35B | |
-21.67% | 3.99B | |
-40.99% | 2.21B | |
+1.11% | 2.01B |
- Stock Market
- Equities
- ONWD Stock
- News Onward Medical N.V.
- Onward Medical N.V. Nine New Patents in Collaboration with Caltech, UCLA, EPFL, and University of Louisville